Search clinical trials for: polyglactin 910 (Vicryl)
Total 6596 results
-
Burzynski Research InstituteCompletedMixed GliomasUnited States
-
Institut Paoli-CalmettesCompletedAcute Myeloid Leukemia | Chronic Myeloid Leukemia | Myelodysplastic SyndromeFrance
-
AbbottCompletedCarcinoma, Renal CellUnited States, Netherlands
-
AbbottCompletedLymphoma, Non-Hodgkin | Hodgkin's LymphomaUnited States
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1-infectionUganda
-
Reinier Haga Orthopedisch CentrumNot yet recruiting
-
New York Medical CollegeJohns Hopkins University; Children's Hospital of Philadelphia; Washington University... and other collaboratorsRecruitingPrimary Immune Deficiency Disorder | Cytomegalovirus InfectionsUnited States
-
Harvard School of Public Health (HSPH)Centers for Disease Control and Prevention; Jos University Teaching HospitalCompleted
-
Nanoscope Therapeutics Inc.Enrolling by invitationStargardt DiseaseUnited States
-
Cairo UniversityUnknown
-
AllerganCompletedBreast ImplantationFrance, Spain, Germany, Israel, United Kingdom
-
AbbottCompletedSarcoma, Soft TissueUnited States
-
Ionis Pharmaceuticals, Inc.CompletedHuntington's DiseaseCanada, United Kingdom, Germany
-
Pheon TherapeuticsNot yet recruitingCervical Cancer | Ovarian Cancer | Lung Cancer | Advanced Solid Tumor | Endometrial Cancer | Advanced Cancer | Colon CancerUnited States
-
Sangamo TherapeuticsActive, not recruitingFabry DiseaseUnited States, United Kingdom, Taiwan, Australia, Germany, Italy, Canada
-
4D Molecular TherapeuticsActive, not recruitingFabry DiseaseUnited States
-
Seoul National University HospitalCompletedNeurogenic Bladder | Detrusor Overactivity | Detrusor UnderactivityKorea, Republic of
-
Allergan MedicalCompletedBreast Augmentation | Breast Reconstruction | Revision of Augmentation or ReconstructionUnited States
-
FA CorporationUniversity of Texas Southwestern Medical CenterEnrolling by invitation
-
Supernus Pharmaceuticals, Inc.CompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
Central Hospital, Nancy, FranceCompletedCyclic Vomiting SyndromeFrance
-
Stanford UniversityCompletedPregnancy | Cesarean SectionUnited States
-
Eskisehir Osmangazi UniversityUnknown
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticCanada, United States, France, United Kingdom
-
4D Molecular TherapeuticsActive, not recruiting
-
McMaster UniversityWithdrawn
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineUnknownadd-on Maintenance Treatment of Patients With Severe Eosinophilic AsthmaChina
-
Supernus Pharmaceuticals, Inc.CompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
Aerami TherapeuticsCompletedPulmonary Arterial HypertensionAustralia
-
Veloce BioPharma LLCCompleted
-
Burzynski Research InstituteNot yet recruiting
-
Burzynski Research InstituteNot yet recruiting
-
BioMarin PharmaceuticalICON plcCompletedMucopolysaccharidosis IV Type A | Morquio A Syndrome | MPS IVAUnited States, United Kingdom, Australia, Taiwan, Belgium, Malaysia, Austria, Canada, Portugal, France, Ireland, Czechia, Denmark, Italy, Netherlands, Poland, Puerto Rico
-
Federal University of São PauloVanessa Marques FerreiraUnknownCoronary Artery Disease | Acute Lung Injury | Coronary Artery Bypass Grafting
-
VA Office of Research and DevelopmentCompletedChronic Kidney Diseases | GoutUnited States
-
Hadassah Medical OrganizationUnknown
-
Beni-Suef UniversityNot yet recruiting
-
Alexza Pharmaceuticals, Inc.CelerionCompleted
-
United States Department of Agriculture (USDA)University of ConnecticutCompleted
-
Assiut UniversityUnknownViral MyocarditisEgypt
-
Deivis de Oliveira guimaraesCompletedParkinson Disease | Alzheimer DiseaseBrazil
-
Mclean HospitalNational Alliance for Research on Schizophrenia and DepressionCompleted
-
GlaxoSmithKlineTerminated
-
Marcin StraburzynskiCompletedUpper Respiratory Tract InfectionsPoland
-
University of MichiganUniversity of Iowa; University of Utah; Emmi SolutionsCompleted